Related Experiment Video
Updated: Mar 22, 2026

Genetic Engineering of an Unconventional Yeast for Renewable Biofuel and Biochemical Production
Published on: September 20, 2016
Biotransformation of gypenoside XVII to compound K by a recombinant β-glucosidase
Fei-Liang Zhong1, Wei-Wei Dong1, Songquan Wu1
1Key Laboratory of Natural Resources of Changbai Mountain and Functional Molecules, Ministry of Education, Yanbian University, Park Road 977, Yanji, 133002, Jilin, People's Republic of China.
Objective:
To study the β-glucosidase gene (bgy1) from Lactobacillus brevis that was cloned and expressed in Escherichia coli BL21 (DE3) and then using it for the biotransformation of gypenoside XVII.
Results:
The bgy1 gene consists of 2283 bp encoding 761 amino acids, with homology to the glycosyl hydrolase family-3 protein domain. The enzyme (Bgy1) hydrolyzed the glucose moieties at the C-3 position and the outer glucose moieties at the C-20 position of gypenoside XVII. Using 0.1 mg enzyme ml(-1) in 20 mM sodium phosphate buffer at 30 °C and pH 6.0, 1 mg gypenoside XVII ml(-1) was transformed into 0.58 mg compound K ml(-1) within 6 h, with a corresponding molar conversion yield of 89 %.
Conclusion:
The recombinant Bgy1 is considered potentially useful for the practical preparation of compound K.
Related Concept Videos
Phase II Reactions: Glucuronidation
Drug Biotransformation: Overview
Production of Pharmaceuticals
Drug Metabolism: Phase II Reactions

